Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nucleoside Therapy in Patients With Telomere Biology Disorders

NCT06817590 is registered in ClinicalTrials.gov with Suneet Agarwal as lead sponsor.

NCT NCT06817590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06817590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nucleoside Therapy in Patients With Telomere Biology Disorders
Lead sponsor
Suneet Agarwal
Phase
Phase 1
Overall status
Recruiting
Start date
September 29, 2025
Completion date
June 30, 2029
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyskeratosis congenita, hoyeraal hreidarsson syndrome, interstitial lung disease due to systemic disease (telomere biology disorder), pulmonary fibrosis, familial (telomere biology disorder), revesz syndrome, telomere biology disorders, telomere biology disorders with bone marrow failure